Cardiovascular effects of electronic cigarettes: A systematic review and meta-analysis

Abstract

Aims

The electronic cigarette is marketed as a safe alternative to tobacco smoking, but electronic cigarette cardiovascular effects remain largely unknown. We systematically reviewed and meta-analysed published literature to investigate the cardiovascular effects and associated risk from electronic cigarette use.

Methods and results

We searched PubMed from January 2000 to November 2017 for published studies assessing the cardiovascular effects of the electronic cigarette. Evidence suggests that the electronic cigarette negatively affects endothelial function, arterial stiffness and the long-term risk for coronary events, but these findings are from single study reports and have not been confirmed in additional studies. Conflicting evidence exists on the effects of the electronic cigarette on heart rate and blood pressure, which is mainly based on non-randomized clinical studies of moderate quality. The meta-analysis of 14 studies (N + 441 participants) suggested that despite the negative acute effects of the electronic cigarette on heart rate (pooled mean difference (MD) + 2.27, 95% confidence interval (CI): 1.64 to 2.89, p < 0.001), diastolic (pooled MD + 2.01 mmHg, 95% CI: 0.62 to 3.39, p + 0.004) and systolic blood pressure (pooled MD + 2.02 mmHg, 95% CI: 0.07 to 3.97, p + 0.042), benefits may be observed in terms of blood pressure regulation when switching from tobacco smoking to chronic electronic cigarette use (systolic blood pressure pooled MD + −7.00, 95% CI: −9.63 to −4.37, p < 0.001; diastolic blood pressure pooled MD + −3.65, 95% CI: −5.71 to −1.59, p + 0.001).

Conclusions

The existing evidence on the cardiovascular effects of the electronic cigarette is concerning, with several unexplored issues. Unless supported by stronger evidence, the electronic cigarette should not be labelled as a cardiovascular safe product. Future studies should delineate whether electronic cigarette use is less hazardous to cardiovascular health than conventional cigarette smoking.

Keywords

Electronic cigarette tobacco blood pressure heart rate cardiovascular

Get full access to this article

View all access options for this article.

References

Schoenborn

Gindi

. Electronic Cigarette Use Among Adults: United States, 2014. NCHS Data Brief 2015, pp. 1–8.

Farsalinos

Poulas

Voudris

et al.

Electronic cigarette use in the European Union: Analysis of a representative sample of 27 460 Europeans from 28 countries. Addiction 2016; 111: 2032–2040.

Saha

Bhalla

Whayne

Jr et al.

Cigarette smoke and adverse health effects: An overview of research trends and future needs. Int J Angiol 2007; 16: 77–83.

Goniewicz

Knysak

Gawron

et al.

Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014; 23: 133–139.

Kosmider

Sobczak

Fik

et al.

Carbonyl compounds in electronic cigarette vapors: Effects of nicotine solvent and battery output voltage. Nicotine Tob Res 2014; 16: 1319–1326.

Hutzler

Paschke

Kruschinski

et al.

Chemical hazards present in liquids and vapors of electronic cigarettes. Arch Toxicol 2014; 88: 1295–1308.

Schweitzer

Chen

Law

et al.

Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures. Am J Physiol Lung Cell Mol Physiol 2015; 309: L175–L187.

Farsalinos

Voudris

Poulas

. Are metals emitted from electronic cigarettes a reason for health concern? A risk-assessment analysis of currently available literature. Int J Environ Res Public Health 2015; 12: 5215–5232.

Williams

Villarreal

Bozhilov

et al.

Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One 2013; 8: e57987–e57987.

10.

Benowitz

Fraiman

. Cardiovascular effects of electronic cigarettes. Nat Rev Cardiol 2017; 14: 447–456.

11.

Alzahrani

Pena

Temesgen

et al.

Association between electronic cigarette use and myocardial infarction. Am J Prev Med 2018; 55: 455–461.

12.

Plaut

Aogaichi

. The separation of DPN-linked and TPN-linked isocitrate dehydrogenase activities of mammalian liver. Biochem Biophys Res Commun 1967; 28: 628–634.

13.

Sterne

Hernan

Reeves

et al.

ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016; 355: i4919–i4919.

14.

Teasdale

Newby

Timpson

et al.

Cigarette smoke but not electronic cigarette aerosol activates a stress response in human coronary artery endothelial cells in culture. Drug Alcohol Depend 2016; 163: 256–260.

15.

Putzhammer

Doppler

Jakschitz

et al.

Vapours of US and EU market leader electronic cigarette brands and liquids are cytotoxic for human vascular endothelial cells. PLoS One 2016; 11: e0157337–e0157337.

16.

Yan

D’Ruiz

. Effects of using electronic cigarettes on nicotine delivery and cardiovascular function in comparison with regular cigarettes. Regul Toxicol Pharmacol 2015; 71: 24–34.

17.

Farsalinos

Tsiapras

Kyrzopoulos

et al.

Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: Comparison with the effects of regular cigarettes. BMC Cardiovasc Disord 2014; 14: 78–78.

18.

Fogt

Levi

Rickards

et al.

Effects of acute vaporized nicotine in non-tobacco users at rest and during exercise. Int J Exerc Sci 2016; 9: 607–615.

19.

Czogala

Cholewinski

Kutek

et al.

[Evaluation of changes in hemodynamic parameters after the use of electronic nicotine delivery systems among regular cigarette smokers]. Przegl Lek 2012; 69: 841–845.

20.

Moheimani

Bhetraratana

Peters

et al.

Sympathomimetic effects of acute e-cigarette use: Role of nicotine and non-nicotine constituents. J Am Heart Assoc 2017; 6: e006579–e006579.

21.

Nides

Leischow

Bhatter

et al.

Nicotine blood levels and short-term smoking reduction with an electronic nicotine delivery system. Am J Health Behav 2014; 38: 265–274.

22.

Oncken

Litt

McLaughlin

et al.

Nicotine concentrations with electronic cigarette use: Effects of sex and flavor. Nicotine Tob Res 2015; 17: 473–478.

23.

Szoltysek-Boldys

Sobczak

Zielinska-Danch

et al.

Influence of inhaled nicotine source on arterial stiffness. Przegl Lek 2014; 71: 572–575.

24.

Spindle

Hiler

Breland

et al.

The influence of a mouthpiece-based topography measurement device on electronic cigarette user’s plasma nicotine concentration, heart rate, and subjective effects under directed and ad libitum use conditions. Nicotine Tob Res 2017; 19: 469–476.

25.

Vlachopoulos

Ioakeimidis

Abdelrasoul

et al.

Electronic cigarette smoking increases aortic stiffness and blood pressure in young smokers. J Am Coll Cardiol 2016; 67: 2802–2803.

26.

Vansickel

Cobb

Weaver

et al.

A clinical laboratory model for evaluating the acute effects of electronic “cigarettes”: Nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev 2010; 19: 1945–1953.

27.

Vansickel

Eissenberg

. Electronic cigarettes: Effective nicotine delivery after acute administration. Nicotine Tob Res 2013; 15: 267–270.

28.

Vansickel

Weaver

Eissenberg

. Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction 2012; 107: 1493–1500.

29.

D’Ruiz

O’Connell

Graff

et al.

Measurement of cardiovascular and pulmonary function endpoints and other physiological effects following partial or complete substitution of cigarettes with electronic cigarettes in adult smokers. Regul Toxicol Pharmacol 2017; 87: 36–53.

30.

Farsalinos

Cibella

Caponnetto

et al.

Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes. Intern Emerg Med 2016; 11: 85–94.

31.

Polosa

Morjaria

Caponnetto

et al.

Blood pressure control in smokers with arterial hypertension who switched to electronic cigarettes. Int J Environ Res Public Health 2016; 13: E1123–E1123.

32.

Moheimani

Bhetraratana

Yin

et al.

Increased cardiac sympathetic activity and oxidative stress in habitual electronic cigarette users: Implications for cardiovascular risk. JAMA Cardiol 2017; 2: 278–284.

33.

Van Staden

Groenewald

Engelbrecht

et al.

Carboxyhaemoglobin levels, health and lifestyle perceptions in smokers converting from tobacco cigarettes to electronic cigarettes. S Afr Med J 2013; 103: 865–868.

34.

Carnevale

Sciarretta

Violi

et al.

Acute impact of tobacco vs electronic cigarette smoking on oxidative stress and vascular function. Chest 2016; 150: 606–612.

35.

Antoniewicz

Bosson

Kuhl

et al.

Electronic cigarettes increase endothelial progenitor cells in the blood of healthy volunteers. Atherosclerosis 2016; 255: 179–185.

36.

St Helen

Havel

Dempsey

et al.

Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes. Addiction 2016; 111: 535–544.

37.

Caponnetto

Campagna

Cibella

et al.

EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: A prospective 12-month randomized control design study. PloS One 2013; 8: e66317–e66317.

38.

Benowitz

. Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988; 319: 1318–1330.

39.

Okamura

Toda

. Mechanism underlying nicotine-induced relaxation in dog saphenous arteries. Eur J Pharmacol 1994; 263: 85–91.

40.

Silva

Scholz

Abe

et al.

Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: Real life setting. BMC Cardiovasc Disord 2016; 16: 2–2.

41.

Benowitz

Pipe

West

et al.

Cardiovascular safety of varenicline, bupropion, and nicotine patch in smokers: A randomized clinical trial. JAMA Intern Med 2018; 178: 622–631.

42.

Blank

Sams

Weaver

et al.

Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokers. Nicotine Tob Res 2008; 10: 417–421.

43.

Eissenberg

. Electronic nicotine delivery devices: Ineffective nicotine delivery and craving suppression after acute administration. Tob Control 2010; 19: 87–88.

44.

Abreu

Bigelow

Fleisher

et al.

Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans. Psychopharmacology 2001; 154: 76–84.

45.

Aune

Schlesinger

Norat

et al.

Tobacco smoking and the risk of atrial fibrillation: A systematic review and meta-analysis of prospective studies. Eur J Prev Cardiol 2018; 25: 1437–1451.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.40 MB